US 10,835,515 B2
CARBOXAMIDE DERIVATIVE AND ITS DIASTEREOMERS IN STABLE CRYSTALLINE FORM
Log In
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

US 10,835,515 B2
CARBOXAMIDE DERIVATIVE AND ITS DIASTEREOMERS IN STABLE CRYSTALLINE FORM
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Kamal A Saeed
Art Unit:
1626 Organic Chemistry
Inventors:
Olli TÖRMÄKANGAS; Terhi HEIKKINEN
Priority:
01/28/16
Filed:
07/01/19
Granted:
11/17/20
Expiration:
01/28/36
Abstract
The present disclosure relates to solid crystalline forms of N—((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide (I) and the diastereomers thereof, and to methods for preparing such crystalline forms. Compound (I) and the diastereomers thereof are potent androgen receptor (AR) modulators useful as a medicament.
Cooperative Patent Classification (CPC)
A61A61K31/4155A61P35/00A61KC07D231/14C07D

Analytics

Cases

Patent Assignments

Citations